Hide Board Information

Show Board Information

Applied Therapeutics Inc. APLT

Board Mod: Add me as mod

Asst Mods:

Last Post: 09/19/2023 6:17:45 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 5

Applied Therapeutics Inc. (NASDAQ: APLT) Stock Message Board

1. APLT Company Profile

    

2. APLT Time & Sales

    

3. APLT Recent News

    

4. APLT Filings

    

5. APLT Financials

    

6. APLT Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

4	$APLT 27% v3,1M C2.53 f63,124M Hod2.57 ML1.22	znewcar1	09/19/2023 6:17:45 PM
3	$APLT 42% v8,9M c1.80 f63,124M Hod2.02 ML1.18	znewcar1	09/06/2023 4:18:46 PM
2	APLT 1% v236K c2.00 f26,2M h2.045 not al of vol.	znewcar1	04/28/2022 10:57:08 PM
1	APLT 28% v946K c2.60 f26,2M H2.65	znewcar1	03/24/2022 10:57:25 PM

Recent Articles

• Tonix Pharmaceuticals Set to Advance TNX-102 SL for Depression
• atai Life Sciences Secures Major Grant for Mental Health Research
• DIRTT Environmental Solutions: Upcoming Investor Conference Events
• Nanox Partners with Monarch to Revolutionize Medical Imaging
• Key Insights on Kaldalón hf. Managers' Transactions
• Sprott Junior Gold Miners ETF Adjusts Index for Market Growth
• Mill Creek's Modera Westside Trail Opens Preleasing for Residents
• Analyzing Lyft's Bullish Trends: What Investors Should Know
• First Mining Gold and Duparquet City Unite for Progress
• Gerald Group Secures $700 Million for Growth in North America
• Streamline Scientific Enhances PCR Reporting for UTI Care
• Join the Celebration of Global Business at NYSE International Day
• Gerald Group Secures $700 Million to Boost North American Trade
• N2OFF Inc. Advances Renewable Energy Projects Across Europe
• Caliber's Strategic Investment in Chainlink Strengthens Portfolio
• Anterix Strengthens Leadership Team for Future Growth
• Valour Digital Securities Unveils Pioneering Bitcoin Staking ETP
• MiNK Therapeutics Enhances iNKT Pipeline with Dr. Hammond's Expertise
• Cytokinetics to Showcase Groundbreaking Research at HFSA 2025
• Minovia Therapeutics Advances Mitochondrial Therapy for MDS
• Zevra Therapeutics Previews Groundbreaking Presentations on Rare Diseases
• Intellia Therapeutics Achieves Key Milestones in HAE Study
• Bowman Consulting Group Secures Major Terminal Project
• Plus Therapeutics Achieves Key Accreditation for CNSide Lab
• Statkraft's Ambitious Upgrade of the Alta Hydropower Plant
• Aveanna Healthcare Strengthens Financial Position Through Refinancing
• Minovia Therapeutics Secures FDA Fast Track for MNV-201 Use
• Biogen’s Acquisition of Alcyone: A New Era in Drug Delivery
• Zevra Therapeutics to Present at Key Medical Conferences
• Anterix Leadership Changes Propel Firm's Growth Strategy
• Gain Therapeutics Advances Parkinson's Treatment with GT-02287
• Bowman Consulting Wins Key Contract for Houston Terminal Project
• MiNK Therapeutics Welcomes Dr. Hammond to Enhance iNKT Trials
• V2X Inc. Secures Major Defense Contract for Global Security
• Aveanna Healthcare Secures Critical Debt Refinancing Deal
• Discovering Modern Living at Modera Westside Trail Community
• Analyst Insights: Fresh Coverage Rating Updates You Should Know
• Håkan Buskhe Steps In as Chair of SKF Automotive Board
• Top Gold Mining Stocks to Watch Amid Soaring Prices
• Understanding the Key to Franchisee Success and Support
• Lingerfelt Sells 1701 Bermuda Industrial Facility for $31.25M
• V2X Receives Major Contract to Strengthen Global Defense
• Valour Digital Securities Introduces a Revolutionary Bitcoin ETP
• Trevi Therapeutics Highlights RIVER Trial at ERS Congress 2025
• La Marquise: Elevating Luxury Jewellery to New Heights
• Reju Introduces Innovative AR Initiative to Address Waste Crisis
• Reju Unveils Innovative AR Experience Addressing Textile Waste
• Empowering Creativity in Sri Lanka: Bybit and Tether Unite
• Beetroot Powder Market Growth Projections and Insights Ahead
• CanLift Equipment Embraces AI for Enhanced Customer Experience